QIAGEN N.V. (QGEN)

NL0015001WM6 - Common Stock

42.34  -1.01 (-2.33%)

After market: 42.34 0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

QIAGEN N.V.

NYSE:QGEN (6/14/2024, 7:04:00 PM)

After market: 42.34 0 (0%)

42.34

-1.01 (-2.33%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month-3.25%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap9.39B
Shares
PE20.65
Fwd PE18.17
Dividend Yield2.94%
Analysts
IPO
Stock Screener Links
Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

QGEN Daily chart

Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 6,178 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Company Info

QIAGEN N.V.

Hulsterweg 82

Venlo LIMBURG 5912

P: 31773556600

CEO: Thierry Bernard

Employees: 6178

Website: https://www.qiagen.com/

QGEN News

News Image2 days ago - QIAGEN N.V.QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs

Latest QCI Interpret release enhances performance of high-throughput NGS labs, improving turn-around time, diagnostic yield and quality of results // New...

News Image3 days ago - QIAGEN N.V.QIAGEN veröffentlicht Nachhaltigkeitsbericht 2023 und hebt Fortschritte bei ESG-Zielen sowie Engagement für nachhaltiges Wachstum hervor

ESG-Engagement wird als strategische Geschäftsinvestition angesehen, die für Stakeholder wie Kunden und Mitarbeitende Mehrwert schafft // Umwelt: Reduktion...

News Image3 days ago - QIAGEN N.V.QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to sustainable growth

ESG commitments recognized as strategic business investments bringing value to stakeholders, including customers and employees // Environment: 15%...

News Image4 days ago - QIAGEN N.V.QIAGEN führt neue QIAcuity digitale PCR-Assays für mikrobielle Anwendungen zur Erforschung und Überwachung von Infektionskrankheiten ein

35 neue laborvalidierte dPCR Microbial DNA Detection Assays auf Forschungsplattform GeneGlobe verfügbar, die eine Vielzahl an Erregern von tropischen...

News Image4 days ago - QIAGEN N.V.QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious disease research and surveillance

35 new wet-lab tested digital PCR Microbial DNA Detection Assays on research platform GeneGlobe target a wide range of pathogens causing tropical diseases,...

News Image9 days ago - QIAGEN N.V.QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition period

NeuMoDx 96 and NeuMoDx 288 Molecular Systems decision taken in light of challenging post-pandemic market development trends // Reaffirms Q2 2024 outlook,...

QGEN Twits

Here you can normally see the latest stock twits on QGEN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example